Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Surgical ClinicsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Global cancer statistics, 2012.CA Cancer J Clin. 2015; 65: 87-108
- Cancer treatment and survivorship statistics, 2019.CA Cancer J Clin. 2019; 69: 363-385
- Racial disparities in preoperative chemotherapy use in gastric cancer patients in the United States: analysis of the National Cancer Data Base, 2006-2014.Cancer. 2018; 124: 998-1007
- Screening and early detection of gastric cancer: east versus west.Surg Clin North Am. 2015; 95: 1053-1066
- Gastric cancer: from aetiology to management: differences between the east and the west.Clin Oncol (R Coll Radiol). 2019; 31: 570-577
- Endoscopic management of early gastric adenocarcinoma and preinvasive gastric lesions.Surg Clin North Am. 2017; 97: 371-385
- The endoscopic diagnosis of early gastric cancer.Ann Gastroenterol. 2013; 26: 11-22
- Prospective evaluation of biopsy number in the diagnosis of esophageal and gastric carcinoma.Gastroenterology. 1982; 82: 228-231
- Diagnostic performance of 64-section CT using CT gastrography in preoperative T staging of gastric cancer according to 7th edition of AJCC cancer staging manual.Eur Radiol. 2012; 22: 654-662
- The role of three-dimensional multidetector CT gastrography in the preoperative imaging of stomach cancer: emphasis on detection and localization of the tumor.Korean J Radiol. 2015; 16: 80-89
- FDG-PET has no definite role in preoperative imaging in gastric cancer.Eur J Surg Oncol. 2009; 35: 449-455
- Improvement in preoperative staging of gastric adenocarcinoma with positron emission tomography.Cancer. 2005; 103: 2383-2390
- FDG PET imaging of locally advanced gastric carcinomas: correlation with endoscopic and histopathological findings.Eur J Nucl Med Mol Imaging. 2003; 30: 288-295
- Selection of patients with gastric adenocarcinoma for laparoscopic staging.Am J Surg. 2006; 191: 134-138
- The value of peritoneal cytology as a preoperative predictor in patients with gastric carcinoma undergoing a curative resection.Ann Surg Oncol. 2005; 12: 347-353
- Positive peritoneal cytology in patients with gastric cancer: natural history and outcome of 291 patients.Ann Surg Oncol. 2010; 17: 3173-3180
- Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer.N Engl J Med. 2006; 355: 11-20
- Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial.Lancet. 2019; 393: 1948-1957
- The importance of surgical margins in gastric cancer.J Surg Oncol. 2016; 113: 277-282
- Japanese gastric cancer treatment guidelines 2014 (ver. 4).Gastric Cancer. 2017; 20: 1-19
- Subtotal versus total gastrectomy for gastric cancer: five-year survival rates in a multicenter randomized Italian trial. Italian Gastrointestinal Tumor Study Group.Ann Surg. 1999; 230: 170-178
- Surgical outcomes and survival after extended multiorgan resection for T4 gastric cancer.Am J Surg. 2012; 203: 107-111
- Multivisceral resection for gastric cancer: a systematic review.Gastric Cancer. 2012; 15: S100-S107
- Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction.N Engl J Med. 2001; 345: 725-730
- Clinical impact of lymphadenectomy extent in resectable gastric cancer of advanced stage.Ann Surg Oncol. 2007; 14: 317-328
- Does a minimum number of 16 retrieved nodes affect survival in curatively resected gastric cancer?.Eur J Surg Oncol. 2015; 41: 779-786
- Standard D2 and modified nodal dissection for gastric adenocarcinoma.Surg Oncol Clin N Am. 2012; 21: 57-70
- Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial.Lancet Oncol. 2010; 11: 439-449
- Randomized controlled trial to evaluate splenectomy in total gastrectomy for proximal gastric carcinoma.Ann Surg. 2017; 265: 277-283
- Morbidity and mortality in the Italian Gastric Cancer Study Group randomized clinical trial of D1 versus D2 resection for gastric cancer.Br J Surg. 2010; 97: 643-649
- Randomized clinical trial comparing survival after D1 or D2 gastrectomy for gastric cancer.Br J Surg. 2014; 101: 23-31
- Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group.Br J Cancer. 1999; 79: 1522-1530
- Extended lymph-node dissection for gastric cancer.N Engl J Med. 1999; 340: 908-914
- Quality control of lymph node dissection in the Dutch randomized trial of D1 and D2 lymph node dissection for gastric cancer.Gastric Cancer. 1998; 1: 152-159
- Learning curve for total gastrectomy with D2 lymph node dissection: cumulative sum analysis for qualified surgery.Ann Surg Oncol. 2006; 13: 1175-1181
- D2 gastrectomy: lessons from a prospective audit of the learning curve.Br J Surg. 1996; 83: 1595-1599
- Influence of overweight on surgical complications for gastric cancer: results from a randomized control trial comparing D2 and extended para-aortic D3 lymphadenectomy (JCOG9501).Ann Surg Oncol. 2007; 14: 355-361
- Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial.Lancet Oncol. 2018; 19: 616-628
- Phase III trial to compare adjuvant chemotherapy with capecitabine and cisplatin versus concurrent chemoradiotherapy in gastric cancer: final report of the adjuvant chemoradiotherapy in stomach tumors trial, including survival and subset analyses.J Clin Oncol. 2015; 33: 3130-3136
- TOPGEAR: a randomised phase III trial of perioperative ECF chemotherapy versus preoperative chemoradiation plus perioperative ECF chemotherapy for resectable gastric cancer (an international, intergroup trial of the AGITG/TROG/EORTC/NCIC CTG).BMC Cancer. 2015; 15: 532
- TOPGEAR: a randomized, phase III trial of perioperative ECF chemotherapy with or without preoperative chemoradiation for resectable gastric cancer: interim results from an international, intergroup trial of the AGITG, TROG, EORTC and CCTG.Ann Surg Oncol. 2017; 24: 2252-2258
- CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in resectable gastric cancer.BMC Cancer. 2018; 18: 877
- Patterns and predictors of weight loss after gastrectomy for cancer.Ann Surg Oncol. 2016; 23: 1639-1645
- Body weight loss after surgery is an independent risk factor for continuation of S-1 adjuvant chemotherapy for gastric cancer.Ann Surg Oncol. 2013; 20: 2000-2006
Article info
Publication history
Published online: March 18, 2020
Identification
Copyright
© 2020 Elsevier Inc. All rights reserved.
